Search research articles
Contact Us
Filters
Showing results (71-80 of 168) with videos related to
Page
of 17
Sort By:
European Archives of Psychiatry and Clinical Neuroscience
|
May 10, 2012
Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder
Alessandro Serretti, Alberto Chiesa, Raffaella Calati, et al.
Journal of Affective Disorders
|
March 30, 2013
Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients
Niki Antypa, Raffaella Calati, Daniel Souery, et al.
International Clinical Psychopharmacology
|
November 7, 2015
The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment--a European multicentre study
Peter Höfer, Alexandra Schosser, Raffaella Calati, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
January 31, 2019
Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder
Ole Köhler-Forsberg, Erik Roj Larsen, Henriette N Buttenschøn, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
November 26, 2021
Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder
Gernot Fugger, Lucie Bartova, Markus Dold, et al.
Journal of Affective Disorders
|
February 1, 2026
Prognostic implications of social anxiety comorbidity in major depressive disorder. Evidence from three large samples with adult and older patients
Paolo Olgiati, Maria Luca, Antonina Luca, et al.
International Clinical Psychopharmacology
|
May 11, 2010
5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder
Magali Noro, Irina Antonijevic, Carlos Forray, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
March 6, 2017
Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance
Chiara Fabbri, Concetta Crisafulli, Raffaella Calati, et al.
Journal of Clinical Psychopharmacology
|
June 23, 2011
Switching antidepressant class does not improve response or remission in treatment-resistant depression
Daniel Souery, Alessandro Serretti, Raffaella Calati, et al.
The International Journal of Neuropsychopharmacology
|
October 12, 2021
The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 168) with videos related to
Sort By:
Page
of 17
European Archives of Psychiatry and Clinical Neuroscience
|
May 10, 2012
Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder
Alessandro Serretti, Alberto Chiesa, Raffaella Calati, et al.
Journal of Affective Disorders
|
March 30, 2013
Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients
Niki Antypa, Raffaella Calati, Daniel Souery, et al.
International Clinical Psychopharmacology
|
November 7, 2015
The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment--a European multicentre study
Peter Höfer, Alexandra Schosser, Raffaella Calati, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
January 31, 2019
Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder
Ole Köhler-Forsberg, Erik Roj Larsen, Henriette N Buttenschøn, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
November 26, 2021
Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder
Gernot Fugger, Lucie Bartova, Markus Dold, et al.
Journal of Affective Disorders
|
February 1, 2026
Prognostic implications of social anxiety comorbidity in major depressive disorder. Evidence from three large samples with adult and older patients
Paolo Olgiati, Maria Luca, Antonina Luca, et al.
International Clinical Psychopharmacology
|
May 11, 2010
5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder
Magali Noro, Irina Antonijevic, Carlos Forray, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
March 6, 2017
Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance
Chiara Fabbri, Concetta Crisafulli, Raffaella Calati, et al.
Journal of Clinical Psychopharmacology
|
June 23, 2011
Switching antidepressant class does not improve response or remission in treatment-resistant depression
Daniel Souery, Alessandro Serretti, Raffaella Calati, et al.
The International Journal of Neuropsychopharmacology
|
October 12, 2021
The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
Page
of 17